Royal Bank of Canada
RVPH

Royal Bank of Canada’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Royal Bank of Canada’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-75
Closed – – 7745
2026
Q1 		$0 Hold
75
– – ﹤0.01% 7613
2025
Q4 		$0 Hold
75
– – ﹤0.01% 7567
2025
Q3 		$1K Hold
75
– – ﹤0.01% 7018
2025
Q2 		$1K Hold
75
– – ﹤0.01% 6926
2025
Q1 		$1K Hold
75
– – ﹤0.01% 6706
2024
Q4 		$3K Buy
+75
New +$2.09K ﹤0.01% 6664
2024
Q3 		– Sell
-12
Closed – – 7359
2024
Q2 		$0 Buy
+12
New +$545 ﹤0.01% 7467
2024
Q1 		– Sell
-2
Closed – – 7515
2023
Q4 		$0 Buy
+2
New +$179 ﹤0.01% 7516
2022
Q4 		– Hold
0
– – – 7642
2022
Q3 		– Hold
0
– – – 7790
2020
Q1 		– Sell
-1,150
Closed -$241K – 6976
2019
Q4 		$241K Buy
1,150
+1
+0.1% +$209 ﹤0.01% 4511
2019
Q3 		$238K Buy
1,149
+683
+147% +$141K ﹤0.01% 4343
2019
Q2 		$96K Buy
466
+21
+5% +$4.27K ﹤0.01% 4900
2019
Q1 		$90K Buy
+445
New +$89.2K ﹤0.01% 4841

Other funds holding RVPH

ECM
EMC Capital Management Houston, Texas $253M AUM
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.62B AUM
MGI
Miller Global Investments Dallas, Texas $121M AUM
MWM
Mosley Wealth Management Anaheim, California $314M AUM

Royal Bank of Canada's RVPH Position: Q2 2026 in Review

Royal Bank of Canada sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 75 shares.

Royal Bank of Canada first reported a position in RVPH in Q1 2019 and held it in 12 quarters. The position peaked at $241K in Q4 2019. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

  • Royal Bank of Canada reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 75 REVIVA PHARMA HLDGS INC shares in Q2 2026.
  • Royal Bank of Canada first reported a position in REVIVA PHARMA HLDGS INC in Q1 2019 and held it in 12 quarters.
  • Royal Bank of Canada's REVIVA PHARMA HLDGS INC position peaked at $241K in Q4 2019.
  • 5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.